oncology drugs

New Payment Model Improves Cancer Care at Oncology GroupCEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
Burnout Hits Oncologists Hard, but Healthcare Systems Can Help
Burnout Hits Oncologists Hard, but Healthcare Systems Can HelpHealthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
Improve Care Coordination in Cancer Care: 2 Key Focus AreasWhen caring for cancer patients, improving care coordination in these two areas is key—and it can help reduce healthcare costs.
Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Top Considerations in Pediatric Cancer Treatment: What Payers Should KnowA Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be CloseIn partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
Five factors driving up the cost of oncology drugsThe high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
What oncologists say about new cancer treatment optionsA new report from Cardinal Health Specialty Solutions gives behind-the-scenes perspectives from oncologists about CAR-T cell therapies, biosimilars and AML therapies (or genomic medicines)
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Unique payer-provider cancer treatment partnershipsUnique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.